nodes	percent_of_prediction	percent_of_DWPC	metapath
Ganciclovir—SLC22A7—Docetaxel—lung cancer	0.158	0.405	CbGbCtD
Ganciclovir—SLC22A7—Methotrexate—lung cancer	0.114	0.292	CbGbCtD
Ganciclovir—SLC22A8—Methotrexate—lung cancer	0.0696	0.178	CbGbCtD
Ganciclovir—SLC22A6—Methotrexate—lung cancer	0.0485	0.124	CbGbCtD
Ganciclovir—SLC22A7—Organic cation/anion/zwitterion transport—SLC22A18—lung cancer	0.00657	0.0992	CbGpPWpGaD
Ganciclovir—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A18—lung cancer	0.00552	0.0834	CbGpPWpGaD
Ganciclovir—SLC22A1—Organic cation transport—SLC22A18—lung cancer	0.00528	0.0798	CbGpPWpGaD
Ganciclovir—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A18—lung cancer	0.00461	0.0696	CbGpPWpGaD
Ganciclovir—SLC22A1—Abacavir transmembrane transport—ABCG2—lung cancer	0.00375	0.0567	CbGpPWpGaD
Ganciclovir—SLC22A1—Organic cation/anion/zwitterion transport—SLC22A18—lung cancer	0.00358	0.0541	CbGpPWpGaD
Ganciclovir—SLC22A1—Abacavir transmembrane transport—ABCB1—lung cancer	0.00234	0.0354	CbGpPWpGaD
Ganciclovir—SLC22A7—Fluoropyrimidine Activity—RRM1—lung cancer	0.0022	0.0332	CbGpPWpGaD
Ganciclovir—SLC22A1—Abacavir transport and metabolism—ABCG2—lung cancer	0.00216	0.0326	CbGpPWpGaD
Ganciclovir—SLC22A7—Fluoropyrimidine Activity—ABCC3—lung cancer	0.00187	0.0282	CbGpPWpGaD
Ganciclovir—SLC22A7—Fluoropyrimidine Activity—ABCG2—lung cancer	0.00152	0.023	CbGpPWpGaD
Ganciclovir—SLC22A7—Fluoropyrimidine Activity—CYP2A6—lung cancer	0.00143	0.0216	CbGpPWpGaD
Ganciclovir—SLC22A1—Abacavir transport and metabolism—ABCB1—lung cancer	0.00135	0.0203	CbGpPWpGaD
Ganciclovir—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A18—lung cancer	0.00132	0.0199	CbGpPWpGaD
Ganciclovir—SLC22A7—Fluoropyrimidine Activity—SMUG1—lung cancer	0.00117	0.0176	CbGpPWpGaD
Ganciclovir—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A18—lung cancer	0.00111	0.0167	CbGpPWpGaD
Ganciclovir—SLC22A7—Fluoropyrimidine Activity—TYMS—lung cancer	0.000933	0.0141	CbGpPWpGaD
Ganciclovir—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A18—lung cancer	0.000923	0.0139	CbGpPWpGaD
Ganciclovir—SLC22A7—Fluoropyrimidine Activity—ERCC2—lung cancer	0.000867	0.0131	CbGpPWpGaD
Ganciclovir—SLC22A7—SLC-mediated transmembrane transport—SLC34A2—lung cancer	0.000789	0.0119	CbGpPWpGaD
Ganciclovir—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A18—lung cancer	0.000717	0.0108	CbGpPWpGaD
Ganciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC34A2—lung cancer	0.000663	0.01	CbGpPWpGaD
Ganciclovir—SLC22A7—SLC-mediated transmembrane transport—SLC22A18—lung cancer	0.000598	0.00903	CbGpPWpGaD
Ganciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC34A2—lung cancer	0.000553	0.00836	CbGpPWpGaD
Ganciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC22A18—lung cancer	0.000502	0.00759	CbGpPWpGaD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—SLC34A2—lung cancer	0.00043	0.0065	CbGpPWpGaD
Ganciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC22A18—lung cancer	0.000419	0.00634	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—SLC34A2—lung cancer	0.000401	0.00606	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmission across Chemical Synapses—GRIK3—lung cancer	0.000374	0.00565	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—SLC34A2—lung cancer	0.000337	0.00509	CbGpPWpGaD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—SLC22A18—lung cancer	0.000326	0.00492	CbGpPWpGaD
Ganciclovir—SLC22A7—Fluoropyrimidine Activity—TP53—lung cancer	0.000309	0.00468	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmission across Chemical Synapses—CHRNB4—lung cancer	0.000305	0.0046	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.000304	0.00459	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—GRIK3—lung cancer	0.000286	0.00433	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmission across Chemical Synapses—CHRNA5—lung cancer	0.000283	0.00428	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—SLC34A2—lung cancer	0.000281	0.00425	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.000255	0.00386	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—CHRNB4—lung cancer	0.000233	0.00353	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmission across Chemical Synapses—CHRNA3—lung cancer	0.000231	0.00349	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLC34A2—lung cancer	0.000218	0.0033	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmission across Chemical Synapses—GNG11—lung cancer	0.000218	0.0033	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—CHRNA5—lung cancer	0.000217	0.00328	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.000213	0.00322	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmission across Chemical Synapses—ADCY1—lung cancer	0.000196	0.00297	CbGpPWpGaD
Ganciclovir—SLC22A7—SLC-mediated transmembrane transport—AVP—lung cancer	0.000188	0.00284	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—ABCC3—lung cancer	0.000182	0.00275	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—CHRNA3—lung cancer	0.000177	0.00267	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—GNG11—lung cancer	0.000167	0.00253	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.000166	0.0025	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—GNG11—lung cancer	0.000165	0.00249	CbGpPWpGaD
Ganciclovir—SLC22A8—SLC-mediated transmembrane transport—AVP—lung cancer	0.000158	0.00239	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—ABCC3—lung cancer	0.000153	0.00231	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—ADCY1—lung cancer	0.00015	0.00227	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000148	0.00224	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000148	0.00224	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—GNG11—lung cancer	0.000139	0.0021	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—TF—lung cancer	0.000138	0.00208	CbGpPWpGaD
Ganciclovir—SLC22A6—SLC-mediated transmembrane transport—AVP—lung cancer	0.000132	0.00199	CbGpPWpGaD
Ganciclovir—Haemoglobin—Methotrexate—lung cancer	0.000129	0.000238	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000129	0.000237	CcSEcCtD
Ganciclovir—Fatigue—Paclitaxel—lung cancer	0.000129	0.000237	CcSEcCtD
Ganciclovir—Haemorrhage—Methotrexate—lung cancer	0.000129	0.000236	CcSEcCtD
Ganciclovir—Hepatitis—Methotrexate—lung cancer	0.000129	0.000236	CcSEcCtD
Ganciclovir—Pollakiuria—Doxorubicin—lung cancer	0.000128	0.000236	CcSEcCtD
Ganciclovir—Asthenia—Gemcitabine—lung cancer	0.000128	0.000236	CcSEcCtD
Ganciclovir—Pain—Paclitaxel—lung cancer	0.000128	0.000235	CcSEcCtD
Ganciclovir—Constipation—Paclitaxel—lung cancer	0.000128	0.000235	CcSEcCtD
Ganciclovir—Confusional state—Docetaxel—lung cancer	0.000128	0.000235	CcSEcCtD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—ABCC3—lung cancer	0.000128	0.00193	CbGpPWpGaD
Ganciclovir—Pharyngitis—Methotrexate—lung cancer	0.000128	0.000235	CcSEcCtD
Ganciclovir—Urinary tract disorder—Methotrexate—lung cancer	0.000127	0.000233	CcSEcCtD
Ganciclovir—Photosensitivity reaction—Doxorubicin—lung cancer	0.000127	0.000233	CcSEcCtD
Ganciclovir—Anaphylactic shock—Docetaxel—lung cancer	0.000127	0.000233	CcSEcCtD
Ganciclovir—Oedema—Docetaxel—lung cancer	0.000127	0.000233	CcSEcCtD
Ganciclovir—Pruritus—Gemcitabine—lung cancer	0.000126	0.000232	CcSEcCtD
Ganciclovir—Urethral disorder—Methotrexate—lung cancer	0.000126	0.000232	CcSEcCtD
Ganciclovir—Infection—Docetaxel—lung cancer	0.000126	0.000231	CcSEcCtD
Ganciclovir—Weight decreased—Doxorubicin—lung cancer	0.000126	0.000231	CcSEcCtD
Ganciclovir—Feeling abnormal—Etoposide—lung cancer	0.000126	0.000231	CcSEcCtD
Ganciclovir—Hyperglycaemia—Doxorubicin—lung cancer	0.000125	0.000231	CcSEcCtD
Ganciclovir—Diarrhoea—Irinotecan—lung cancer	0.000125	0.000231	CcSEcCtD
Ganciclovir—Pneumonia—Doxorubicin—lung cancer	0.000125	0.000229	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Etoposide—lung cancer	0.000125	0.000229	CcSEcCtD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000125	0.00188	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000125	0.00188	CbGpPWpGaD
Ganciclovir—Thrombocytopenia—Docetaxel—lung cancer	0.000124	0.000228	CcSEcCtD
Ganciclovir—Infestation NOS—Doxorubicin—lung cancer	0.000124	0.000228	CcSEcCtD
Ganciclovir—Infestation—Doxorubicin—lung cancer	0.000124	0.000228	CcSEcCtD
Ganciclovir—Visual impairment—Methotrexate—lung cancer	0.000124	0.000228	CcSEcCtD
Ganciclovir—Tachycardia—Docetaxel—lung cancer	0.000124	0.000227	CcSEcCtD
Ganciclovir—Feeling abnormal—Paclitaxel—lung cancer	0.000123	0.000227	CcSEcCtD
Ganciclovir—Skin disorder—Docetaxel—lung cancer	0.000123	0.000226	CcSEcCtD
Ganciclovir—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.000123	0.000226	CcSEcCtD
Ganciclovir—Hypersensitivity—Cisplatin—lung cancer	0.000123	0.000225	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Paclitaxel—lung cancer	0.000122	0.000225	CcSEcCtD
Ganciclovir—Diarrhoea—Gemcitabine—lung cancer	0.000122	0.000225	CcSEcCtD
Ganciclovir—Renal failure—Doxorubicin—lung cancer	0.000122	0.000224	CcSEcCtD
Ganciclovir—Erythema multiforme—Methotrexate—lung cancer	0.000122	0.000224	CcSEcCtD
Ganciclovir—Neuropathy peripheral—Doxorubicin—lung cancer	0.000122	0.000224	CcSEcCtD
Ganciclovir—Dizziness—Irinotecan—lung cancer	0.000121	0.000223	CcSEcCtD
Ganciclovir—Urticaria—Etoposide—lung cancer	0.000121	0.000223	CcSEcCtD
Ganciclovir—Jaundice—Doxorubicin—lung cancer	0.000121	0.000222	CcSEcCtD
Ganciclovir—Stomatitis—Doxorubicin—lung cancer	0.000121	0.000222	CcSEcCtD
Ganciclovir—Anorexia—Docetaxel—lung cancer	0.000121	0.000222	CcSEcCtD
Ganciclovir—Body temperature increased—Etoposide—lung cancer	0.000121	0.000222	CcSEcCtD
Ganciclovir—Abdominal pain—Etoposide—lung cancer	0.000121	0.000222	CcSEcCtD
Ganciclovir—Urinary tract infection—Doxorubicin—lung cancer	0.000121	0.000222	CcSEcCtD
Ganciclovir—Conjunctivitis—Doxorubicin—lung cancer	0.000121	0.000222	CcSEcCtD
Ganciclovir—Tinnitus—Methotrexate—lung cancer	0.00012	0.00022	CcSEcCtD
Ganciclovir—Asthenia—Cisplatin—lung cancer	0.000119	0.00022	CcSEcCtD
Ganciclovir—Sweating—Doxorubicin—lung cancer	0.000119	0.000219	CcSEcCtD
Ganciclovir—Urticaria—Paclitaxel—lung cancer	0.000119	0.000218	CcSEcCtD
Ganciclovir—Hypotension—Docetaxel—lung cancer	0.000118	0.000218	CcSEcCtD
Ganciclovir—Haematuria—Doxorubicin—lung cancer	0.000118	0.000217	CcSEcCtD
Ganciclovir—Body temperature increased—Paclitaxel—lung cancer	0.000118	0.000217	CcSEcCtD
Ganciclovir—Abdominal pain—Paclitaxel—lung cancer	0.000118	0.000217	CcSEcCtD
Ganciclovir—Hepatobiliary disease—Doxorubicin—lung cancer	0.000117	0.000216	CcSEcCtD
Ganciclovir—Angiopathy—Methotrexate—lung cancer	0.000117	0.000214	CcSEcCtD
Ganciclovir—Vomiting—Irinotecan—lung cancer	0.000117	0.000214	CcSEcCtD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—TF—lung cancer	0.000116	0.00175	CbGpPWpGaD
Ganciclovir—Mediastinal disorder—Methotrexate—lung cancer	0.000116	0.000213	CcSEcCtD
Ganciclovir—Agranulocytosis—Doxorubicin—lung cancer	0.000116	0.000213	CcSEcCtD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—GNG11—lung cancer	0.000116	0.00175	CbGpPWpGaD
Ganciclovir—Rash—Irinotecan—lung cancer	0.000116	0.000213	CcSEcCtD
Ganciclovir—Dermatitis—Irinotecan—lung cancer	0.000115	0.000212	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000115	0.000212	CcSEcCtD
Ganciclovir—Chills—Methotrexate—lung cancer	0.000115	0.000212	CcSEcCtD
Ganciclovir—Headache—Irinotecan—lung cancer	0.000115	0.000211	CcSEcCtD
Ganciclovir—Insomnia—Docetaxel—lung cancer	0.000115	0.000211	CcSEcCtD
Ganciclovir—SLC22A7—SLC-mediated transmembrane transport—ALB—lung cancer	0.000114	0.00172	CbGpPWpGaD
Ganciclovir—Diarrhoea—Cisplatin—lung cancer	0.000114	0.000209	CcSEcCtD
Ganciclovir—Paraesthesia—Docetaxel—lung cancer	0.000114	0.000209	CcSEcCtD
Ganciclovir—Alopecia—Methotrexate—lung cancer	0.000114	0.000209	CcSEcCtD
Ganciclovir—Vomiting—Gemcitabine—lung cancer	0.000114	0.000209	CcSEcCtD
Ganciclovir—Dyspnoea—Docetaxel—lung cancer	0.000113	0.000208	CcSEcCtD
Ganciclovir—Somnolence—Docetaxel—lung cancer	0.000113	0.000207	CcSEcCtD
Ganciclovir—Mental disorder—Methotrexate—lung cancer	0.000113	0.000207	CcSEcCtD
Ganciclovir—Rash—Gemcitabine—lung cancer	0.000113	0.000207	CcSEcCtD
Ganciclovir—Dermatitis—Gemcitabine—lung cancer	0.000112	0.000207	CcSEcCtD
Ganciclovir—Hypersensitivity—Etoposide—lung cancer	0.000112	0.000207	CcSEcCtD
Ganciclovir—Malnutrition—Methotrexate—lung cancer	0.000112	0.000206	CcSEcCtD
Ganciclovir—Haemoglobin—Doxorubicin—lung cancer	0.000112	0.000206	CcSEcCtD
Ganciclovir—Headache—Gemcitabine—lung cancer	0.000112	0.000206	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—AZIN2—lung cancer	0.000112	0.00169	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—COL4A3BP—lung cancer	0.000112	0.00169	CbGpPWpGaD
Ganciclovir—Rhinitis—Doxorubicin—lung cancer	0.000112	0.000205	CcSEcCtD
Ganciclovir—Dyspepsia—Docetaxel—lung cancer	0.000112	0.000205	CcSEcCtD
Ganciclovir—Hepatitis—Doxorubicin—lung cancer	0.000111	0.000205	CcSEcCtD
Ganciclovir—Haemorrhage—Doxorubicin—lung cancer	0.000111	0.000205	CcSEcCtD
Ganciclovir—Hypoaesthesia—Doxorubicin—lung cancer	0.000111	0.000204	CcSEcCtD
Ganciclovir—Pharyngitis—Doxorubicin—lung cancer	0.00011	0.000203	CcSEcCtD
Ganciclovir—Decreased appetite—Docetaxel—lung cancer	0.00011	0.000203	CcSEcCtD
Ganciclovir—Hypersensitivity—Paclitaxel—lung cancer	0.00011	0.000203	CcSEcCtD
Ganciclovir—Urinary tract disorder—Doxorubicin—lung cancer	0.00011	0.000202	CcSEcCtD
Ganciclovir—Oedema peripheral—Doxorubicin—lung cancer	0.00011	0.000202	CcSEcCtD
Ganciclovir—Dysgeusia—Methotrexate—lung cancer	0.00011	0.000202	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Docetaxel—lung cancer	0.000109	0.000201	CcSEcCtD
Ganciclovir—Asthenia—Etoposide—lung cancer	0.000109	0.000201	CcSEcCtD
Ganciclovir—Connective tissue disorder—Doxorubicin—lung cancer	0.000109	0.000201	CcSEcCtD
Ganciclovir—Fatigue—Docetaxel—lung cancer	0.000109	0.000201	CcSEcCtD
Ganciclovir—Urethral disorder—Doxorubicin—lung cancer	0.000109	0.000201	CcSEcCtD
Ganciclovir—Nausea—Irinotecan—lung cancer	0.000109	0.0002	CcSEcCtD
Ganciclovir—Pain—Docetaxel—lung cancer	0.000108	0.000199	CcSEcCtD
Ganciclovir—Constipation—Docetaxel—lung cancer	0.000108	0.000199	CcSEcCtD
Ganciclovir—Back pain—Methotrexate—lung cancer	0.000108	0.000199	CcSEcCtD
Ganciclovir—Pruritus—Etoposide—lung cancer	0.000108	0.000198	CcSEcCtD
Ganciclovir—Visual impairment—Doxorubicin—lung cancer	0.000107	0.000197	CcSEcCtD
Ganciclovir—Asthenia—Paclitaxel—lung cancer	0.000107	0.000197	CcSEcCtD
Ganciclovir—Nausea—Gemcitabine—lung cancer	0.000106	0.000195	CcSEcCtD
Ganciclovir—Vomiting—Cisplatin—lung cancer	0.000106	0.000195	CcSEcCtD
Ganciclovir—Pruritus—Paclitaxel—lung cancer	0.000106	0.000195	CcSEcCtD
Ganciclovir—Vision blurred—Methotrexate—lung cancer	0.000105	0.000194	CcSEcCtD
Ganciclovir—Erythema multiforme—Doxorubicin—lung cancer	0.000105	0.000194	CcSEcCtD
Ganciclovir—Rash—Cisplatin—lung cancer	0.000105	0.000193	CcSEcCtD
Ganciclovir—Dermatitis—Cisplatin—lung cancer	0.000105	0.000193	CcSEcCtD
Ganciclovir—Feeling abnormal—Docetaxel—lung cancer	0.000104	0.000192	CcSEcCtD
Ganciclovir—Diarrhoea—Etoposide—lung cancer	0.000104	0.000192	CcSEcCtD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000104	0.00157	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000104	0.00157	CbGpPWpGaD
Ganciclovir—Ill-defined disorder—Methotrexate—lung cancer	0.000104	0.000191	CcSEcCtD
Ganciclovir—Tinnitus—Doxorubicin—lung cancer	0.000104	0.000191	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Docetaxel—lung cancer	0.000104	0.000191	CcSEcCtD
Ganciclovir—Anaemia—Methotrexate—lung cancer	0.000103	0.00019	CcSEcCtD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—AVP—lung cancer	0.000103	0.00155	CbGpPWpGaD
Ganciclovir—Diarrhoea—Paclitaxel—lung cancer	0.000102	0.000188	CcSEcCtD
Ganciclovir—Angiopathy—Doxorubicin—lung cancer	0.000101	0.000186	CcSEcCtD
Ganciclovir—Malaise—Methotrexate—lung cancer	0.000101	0.000186	CcSEcCtD
Ganciclovir—Dizziness—Etoposide—lung cancer	0.000101	0.000185	CcSEcCtD
Ganciclovir—Vertigo—Methotrexate—lung cancer	0.000101	0.000185	CcSEcCtD
Ganciclovir—Mediastinal disorder—Doxorubicin—lung cancer	0.0001	0.000184	CcSEcCtD
Ganciclovir—Body temperature increased—Docetaxel—lung cancer	0.0001	0.000184	CcSEcCtD
Ganciclovir—Abdominal pain—Docetaxel—lung cancer	0.0001	0.000184	CcSEcCtD
Ganciclovir—Leukopenia—Methotrexate—lung cancer	0.0001	0.000184	CcSEcCtD
Ganciclovir—Chills—Doxorubicin—lung cancer	9.99e-05	0.000184	CcSEcCtD
Ganciclovir—Arrhythmia—Doxorubicin—lung cancer	9.94e-05	0.000183	CcSEcCtD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—ABCC3—lung cancer	9.92e-05	0.0015	CbGpPWpGaD
Ganciclovir—Dizziness—Paclitaxel—lung cancer	9.89e-05	0.000182	CcSEcCtD
Ganciclovir—Nausea—Cisplatin—lung cancer	9.89e-05	0.000182	CcSEcCtD
Ganciclovir—Alopecia—Doxorubicin—lung cancer	9.84e-05	0.000181	CcSEcCtD
Ganciclovir—Cough—Methotrexate—lung cancer	9.77e-05	0.00018	CcSEcCtD
Ganciclovir—Mental disorder—Doxorubicin—lung cancer	9.75e-05	0.000179	CcSEcCtD
Ganciclovir—Convulsion—Methotrexate—lung cancer	9.7e-05	0.000178	CcSEcCtD
Ganciclovir—Vomiting—Etoposide—lung cancer	9.69e-05	0.000178	CcSEcCtD
Ganciclovir—Malnutrition—Doxorubicin—lung cancer	9.69e-05	0.000178	CcSEcCtD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—TF—lung cancer	9.67e-05	0.00146	CbGpPWpGaD
Ganciclovir—Rash—Etoposide—lung cancer	9.61e-05	0.000177	CcSEcCtD
Ganciclovir—Dermatitis—Etoposide—lung cancer	9.61e-05	0.000177	CcSEcCtD
Ganciclovir—SLC22A8—SLC-mediated transmembrane transport—ALB—lung cancer	9.58e-05	0.00145	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—AVP—lung cancer	9.56e-05	0.00144	CbGpPWpGaD
Ganciclovir—Headache—Etoposide—lung cancer	9.55e-05	0.000176	CcSEcCtD
Ganciclovir—Flatulence—Doxorubicin—lung cancer	9.55e-05	0.000176	CcSEcCtD
Ganciclovir—Arthralgia—Methotrexate—lung cancer	9.53e-05	0.000175	CcSEcCtD
Ganciclovir—Chest pain—Methotrexate—lung cancer	9.53e-05	0.000175	CcSEcCtD
Ganciclovir—Myalgia—Methotrexate—lung cancer	9.53e-05	0.000175	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—ATP5H—lung cancer	9.51e-05	0.00144	CbGpPWpGaD
Ganciclovir—Tension—Doxorubicin—lung cancer	9.51e-05	0.000175	CcSEcCtD
Ganciclovir—Vomiting—Paclitaxel—lung cancer	9.51e-05	0.000175	CcSEcCtD
Ganciclovir—Dysgeusia—Doxorubicin—lung cancer	9.49e-05	0.000174	CcSEcCtD
Ganciclovir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	9.46e-05	0.000174	CcSEcCtD
Ganciclovir—Rash—Paclitaxel—lung cancer	9.43e-05	0.000173	CcSEcCtD
Ganciclovir—Dermatitis—Paclitaxel—lung cancer	9.42e-05	0.000173	CcSEcCtD
Ganciclovir—Discomfort—Methotrexate—lung cancer	9.41e-05	0.000173	CcSEcCtD
Ganciclovir—Nervousness—Doxorubicin—lung cancer	9.41e-05	0.000173	CcSEcCtD
Ganciclovir—Back pain—Doxorubicin—lung cancer	9.37e-05	0.000172	CcSEcCtD
Ganciclovir—Headache—Paclitaxel—lung cancer	9.37e-05	0.000172	CcSEcCtD
Ganciclovir—Hypersensitivity—Docetaxel—lung cancer	9.34e-05	0.000172	CcSEcCtD
Ganciclovir—Muscle spasms—Doxorubicin—lung cancer	9.32e-05	0.000171	CcSEcCtD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—ABCB1—lung cancer	9.26e-05	0.0014	CbGpPWpGaD
Ganciclovir—Confusional state—Methotrexate—lung cancer	9.21e-05	0.000169	CcSEcCtD
Ganciclovir—Anaphylactic shock—Methotrexate—lung cancer	9.13e-05	0.000168	CcSEcCtD
Ganciclovir—Vision blurred—Doxorubicin—lung cancer	9.13e-05	0.000168	CcSEcCtD
Ganciclovir—Asthenia—Docetaxel—lung cancer	9.09e-05	0.000167	CcSEcCtD
Ganciclovir—Infection—Methotrexate—lung cancer	9.07e-05	0.000167	CcSEcCtD
Ganciclovir—Nausea—Etoposide—lung cancer	9.06e-05	0.000167	CcSEcCtD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—GNG11—lung cancer	8.99e-05	0.00136	CbGpPWpGaD
Ganciclovir—Ill-defined disorder—Doxorubicin—lung cancer	8.99e-05	0.000165	CcSEcCtD
Ganciclovir—Pruritus—Docetaxel—lung cancer	8.97e-05	0.000165	CcSEcCtD
Ganciclovir—Anaemia—Doxorubicin—lung cancer	8.96e-05	0.000165	CcSEcCtD
Ganciclovir—Thrombocytopenia—Methotrexate—lung cancer	8.94e-05	0.000164	CcSEcCtD
Ganciclovir—Agitation—Doxorubicin—lung cancer	8.91e-05	0.000164	CcSEcCtD
Ganciclovir—Nausea—Paclitaxel—lung cancer	8.88e-05	0.000163	CcSEcCtD
Ganciclovir—Skin disorder—Methotrexate—lung cancer	8.87e-05	0.000163	CcSEcCtD
Ganciclovir—Hyperhidrosis—Methotrexate—lung cancer	8.83e-05	0.000162	CcSEcCtD
Ganciclovir—Malaise—Doxorubicin—lung cancer	8.74e-05	0.000161	CcSEcCtD
Ganciclovir—Vertigo—Doxorubicin—lung cancer	8.71e-05	0.00016	CcSEcCtD
Ganciclovir—Anorexia—Methotrexate—lung cancer	8.71e-05	0.00016	CcSEcCtD
Ganciclovir—Leukopenia—Doxorubicin—lung cancer	8.67e-05	0.00016	CcSEcCtD
Ganciclovir—Diarrhoea—Docetaxel—lung cancer	8.67e-05	0.000159	CcSEcCtD
Ganciclovir—Hypotension—Methotrexate—lung cancer	8.53e-05	0.000157	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—PLBD1—lung cancer	8.48e-05	0.00128	CbGpPWpGaD
Ganciclovir—Cough—Doxorubicin—lung cancer	8.46e-05	0.000155	CcSEcCtD
Ganciclovir—Convulsion—Doxorubicin—lung cancer	8.4e-05	0.000154	CcSEcCtD
Ganciclovir—Dizziness—Docetaxel—lung cancer	8.38e-05	0.000154	CcSEcCtD
Ganciclovir—Hypertension—Doxorubicin—lung cancer	8.37e-05	0.000154	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Methotrexate—lung cancer	8.32e-05	0.000153	CcSEcCtD
Ganciclovir—SLC22A1—Transmission across Chemical Synapses—BRAF—lung cancer	8.3e-05	0.00125	CbGpPWpGaD
Ganciclovir—Insomnia—Methotrexate—lung cancer	8.26e-05	0.000152	CcSEcCtD
Ganciclovir—Myalgia—Doxorubicin—lung cancer	8.25e-05	0.000152	CcSEcCtD
Ganciclovir—Arthralgia—Doxorubicin—lung cancer	8.25e-05	0.000152	CcSEcCtD
Ganciclovir—Chest pain—Doxorubicin—lung cancer	8.25e-05	0.000152	CcSEcCtD
Ganciclovir—Anxiety—Doxorubicin—lung cancer	8.22e-05	0.000151	CcSEcCtD
Ganciclovir—Paraesthesia—Methotrexate—lung cancer	8.2e-05	0.000151	CcSEcCtD
Ganciclovir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	8.19e-05	0.000151	CcSEcCtD
Ganciclovir—Discomfort—Doxorubicin—lung cancer	8.15e-05	0.00015	CcSEcCtD
Ganciclovir—Dyspnoea—Methotrexate—lung cancer	8.14e-05	0.00015	CcSEcCtD
Ganciclovir—Somnolence—Methotrexate—lung cancer	8.12e-05	0.000149	CcSEcCtD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—ADCY1—lung cancer	8.08e-05	0.00122	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—ABCG2—lung cancer	8.08e-05	0.00122	CbGpPWpGaD
Ganciclovir—Dry mouth—Doxorubicin—lung cancer	8.07e-05	0.000148	CcSEcCtD
Ganciclovir—Vomiting—Docetaxel—lung cancer	8.06e-05	0.000148	CcSEcCtD
Ganciclovir—Dyspepsia—Methotrexate—lung cancer	8.04e-05	0.000148	CcSEcCtD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—AVP—lung cancer	8.03e-05	0.00121	CbGpPWpGaD
Ganciclovir—SLC22A6—SLC-mediated transmembrane transport—ALB—lung cancer	7.99e-05	0.00121	CbGpPWpGaD
Ganciclovir—Rash—Docetaxel—lung cancer	7.99e-05	0.000147	CcSEcCtD
Ganciclovir—Dermatitis—Docetaxel—lung cancer	7.98e-05	0.000147	CcSEcCtD
Ganciclovir—Confusional state—Doxorubicin—lung cancer	7.97e-05	0.000147	CcSEcCtD
Ganciclovir—Decreased appetite—Methotrexate—lung cancer	7.94e-05	0.000146	CcSEcCtD
Ganciclovir—Headache—Docetaxel—lung cancer	7.94e-05	0.000146	CcSEcCtD
Ganciclovir—Oedema—Doxorubicin—lung cancer	7.91e-05	0.000145	CcSEcCtD
Ganciclovir—Anaphylactic shock—Doxorubicin—lung cancer	7.91e-05	0.000145	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Methotrexate—lung cancer	7.89e-05	0.000145	CcSEcCtD
Ganciclovir—Fatigue—Methotrexate—lung cancer	7.87e-05	0.000145	CcSEcCtD
Ganciclovir—Infection—Doxorubicin—lung cancer	7.86e-05	0.000144	CcSEcCtD
Ganciclovir—Pain—Methotrexate—lung cancer	7.81e-05	0.000144	CcSEcCtD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—ABCB1—lung cancer	7.78e-05	0.00118	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—HSD17B10—lung cancer	7.75e-05	0.00117	CbGpPWpGaD
Ganciclovir—Thrombocytopenia—Doxorubicin—lung cancer	7.74e-05	0.000142	CcSEcCtD
Ganciclovir—Tachycardia—Doxorubicin—lung cancer	7.72e-05	0.000142	CcSEcCtD
Ganciclovir—Skin disorder—Doxorubicin—lung cancer	7.68e-05	0.000141	CcSEcCtD
Ganciclovir—Hyperhidrosis—Doxorubicin—lung cancer	7.65e-05	0.000141	CcSEcCtD
Ganciclovir—Anorexia—Doxorubicin—lung cancer	7.54e-05	0.000139	CcSEcCtD
Ganciclovir—Nausea—Docetaxel—lung cancer	7.53e-05	0.000138	CcSEcCtD
Ganciclovir—Feeling abnormal—Methotrexate—lung cancer	7.53e-05	0.000138	CcSEcCtD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—TF—lung cancer	7.52e-05	0.00114	CbGpPWpGaD
Ganciclovir—Gastrointestinal pain—Methotrexate—lung cancer	7.47e-05	0.000137	CcSEcCtD
Ganciclovir—Hypotension—Doxorubicin—lung cancer	7.39e-05	0.000136	CcSEcCtD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—APOA1—lung cancer	7.31e-05	0.0011	CbGpPWpGaD
Ganciclovir—Urticaria—Methotrexate—lung cancer	7.26e-05	0.000133	CcSEcCtD
Ganciclovir—Body temperature increased—Methotrexate—lung cancer	7.22e-05	0.000133	CcSEcCtD
Ganciclovir—Abdominal pain—Methotrexate—lung cancer	7.22e-05	0.000133	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—CKB—lung cancer	7.21e-05	0.00109	CbGpPWpGaD
Ganciclovir—Musculoskeletal discomfort—Doxorubicin—lung cancer	7.21e-05	0.000132	CcSEcCtD
Ganciclovir—Insomnia—Doxorubicin—lung cancer	7.15e-05	0.000132	CcSEcCtD
Ganciclovir—Paraesthesia—Doxorubicin—lung cancer	7.1e-05	0.000131	CcSEcCtD
Ganciclovir—Dyspnoea—Doxorubicin—lung cancer	7.05e-05	0.00013	CcSEcCtD
Ganciclovir—Somnolence—Doxorubicin—lung cancer	7.03e-05	0.000129	CcSEcCtD
Ganciclovir—Dyspepsia—Doxorubicin—lung cancer	6.96e-05	0.000128	CcSEcCtD
Ganciclovir—SLC22A1—Transmission across Chemical Synapses—MDM2—lung cancer	6.95e-05	0.00105	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmission across Chemical Synapses—RAF1—lung cancer	6.93e-05	0.00105	CbGpPWpGaD
Ganciclovir—Decreased appetite—Doxorubicin—lung cancer	6.87e-05	0.000126	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Doxorubicin—lung cancer	6.83e-05	0.000126	CcSEcCtD
Ganciclovir—Fatigue—Doxorubicin—lung cancer	6.82e-05	0.000125	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—GSTM2—lung cancer	6.78e-05	0.00102	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CNDP2—lung cancer	6.78e-05	0.00102	CbGpPWpGaD
Ganciclovir—Pain—Doxorubicin—lung cancer	6.76e-05	0.000124	CcSEcCtD
Ganciclovir—Constipation—Doxorubicin—lung cancer	6.76e-05	0.000124	CcSEcCtD
Ganciclovir—Hypersensitivity—Methotrexate—lung cancer	6.73e-05	0.000124	CcSEcCtD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—AVP—lung cancer	6.7e-05	0.00101	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—MTMR3—lung cancer	6.59e-05	0.000996	CbGpPWpGaD
Ganciclovir—Asthenia—Methotrexate—lung cancer	6.55e-05	0.00012	CcSEcCtD
Ganciclovir—Feeling abnormal—Doxorubicin—lung cancer	6.52e-05	0.00012	CcSEcCtD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—ABCB1—lung cancer	6.49e-05	0.000981	CbGpPWpGaD
Ganciclovir—Gastrointestinal pain—Doxorubicin—lung cancer	6.47e-05	0.000119	CcSEcCtD
Ganciclovir—Pruritus—Methotrexate—lung cancer	6.46e-05	0.000119	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—PGAM1—lung cancer	6.42e-05	0.000971	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—BRAF—lung cancer	6.36e-05	0.000961	CbGpPWpGaD
Ganciclovir—Urticaria—Doxorubicin—lung cancer	6.28e-05	0.000116	CcSEcCtD
Ganciclovir—Abdominal pain—Doxorubicin—lung cancer	6.25e-05	0.000115	CcSEcCtD
Ganciclovir—Body temperature increased—Doxorubicin—lung cancer	6.25e-05	0.000115	CcSEcCtD
Ganciclovir—Diarrhoea—Methotrexate—lung cancer	6.25e-05	0.000115	CcSEcCtD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—ALB—lung cancer	6.21e-05	0.000939	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—CREBBP—lung cancer	6.19e-05	0.000935	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—APOA1—lung cancer	6.14e-05	0.000928	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CYP2A7—lung cancer	6.13e-05	0.000926	CbGpPWpGaD
Ganciclovir—Dizziness—Methotrexate—lung cancer	6.04e-05	0.000111	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—SDC4—lung cancer	6e-05	0.000907	CbGpPWpGaD
Ganciclovir—Hypersensitivity—Doxorubicin—lung cancer	5.83e-05	0.000107	CcSEcCtD
Ganciclovir—Vomiting—Methotrexate—lung cancer	5.81e-05	0.000107	CcSEcCtD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—ALB—lung cancer	5.79e-05	0.000875	CbGpPWpGaD
Ganciclovir—Rash—Methotrexate—lung cancer	5.76e-05	0.000106	CcSEcCtD
Ganciclovir—Dermatitis—Methotrexate—lung cancer	5.75e-05	0.000106	CcSEcCtD
Ganciclovir—Headache—Methotrexate—lung cancer	5.72e-05	0.000105	CcSEcCtD
Ganciclovir—Asthenia—Doxorubicin—lung cancer	5.67e-05	0.000104	CcSEcCtD
Ganciclovir—Pruritus—Doxorubicin—lung cancer	5.6e-05	0.000103	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—RRM1—lung cancer	5.46e-05	0.000826	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—GSTA3—lung cancer	5.46e-05	0.000826	CbGpPWpGaD
Ganciclovir—Nausea—Methotrexate—lung cancer	5.43e-05	9.98e-05	CcSEcCtD
Ganciclovir—Diarrhoea—Doxorubicin—lung cancer	5.41e-05	9.95e-05	CcSEcCtD
Ganciclovir—SLC22A1—Neuronal System—MDM2—lung cancer	5.33e-05	0.000805	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—RAF1—lung cancer	5.31e-05	0.000802	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—RAF1—lung cancer	5.24e-05	0.000792	CbGpPWpGaD
Ganciclovir—Dizziness—Doxorubicin—lung cancer	5.23e-05	9.62e-05	CcSEcCtD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—AVP—lung cancer	5.21e-05	0.000787	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—CREBBP—lung cancer	5.2e-05	0.000786	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—B4GALT5—lung cancer	5.14e-05	0.000776	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—APOA1—lung cancer	5.13e-05	0.000775	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—ABCB1—lung cancer	5.05e-05	0.000763	CbGpPWpGaD
Ganciclovir—Vomiting—Doxorubicin—lung cancer	5.03e-05	9.25e-05	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—GSTA4—lung cancer	5e-05	0.000755	CbGpPWpGaD
Ganciclovir—Rash—Doxorubicin—lung cancer	4.99e-05	9.17e-05	CcSEcCtD
Ganciclovir—Dermatitis—Doxorubicin—lung cancer	4.98e-05	9.16e-05	CcSEcCtD
Ganciclovir—Headache—Doxorubicin—lung cancer	4.95e-05	9.11e-05	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—GSTA2—lung cancer	4.87e-05	0.000736	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—ALB—lung cancer	4.87e-05	0.000736	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—GSTA1—lung cancer	4.7e-05	0.00071	CbGpPWpGaD
Ganciclovir—Nausea—Doxorubicin—lung cancer	4.7e-05	8.64e-05	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—ABCC3—lung cancer	4.65e-05	0.000702	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—AKR1C1—lung cancer	4.5e-05	0.00068	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—RAF1—lung cancer	4.4e-05	0.000665	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—UGT1A1—lung cancer	4.37e-05	0.00066	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—CREBBP—lung cancer	4.34e-05	0.000656	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—GNG11—lung cancer	4.21e-05	0.000637	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—ALB—lung cancer	4.06e-05	0.000614	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—ALDOA—lung cancer	4.01e-05	0.000606	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—APOA1—lung cancer	3.98e-05	0.000602	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—NCOA3—lung cancer	3.89e-05	0.000588	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmission across Chemical Synapses—HRAS—lung cancer	3.82e-05	0.000577	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—ABCG2—lung cancer	3.79e-05	0.000572	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—ADCY1—lung cancer	3.79e-05	0.000572	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—ENO2—lung cancer	3.71e-05	0.000561	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—HPGDS—lung cancer	3.71e-05	0.000561	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—PPP2R1B—lung cancer	3.69e-05	0.000558	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—RAF1—lung cancer	3.67e-05	0.000555	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—GSTT1—lung cancer	3.6e-05	0.000544	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—GCLC—lung cancer	3.56e-05	0.000538	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CYP2A6—lung cancer	3.56e-05	0.000538	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—ENO1—lung cancer	3.38e-05	0.00051	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—CREBBP—lung cancer	3.37e-05	0.00051	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—ALB—lung cancer	3.16e-05	0.000477	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CYP2E1—lung cancer	3.03e-05	0.000458	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—NQO1—lung cancer	2.99e-05	0.000452	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—HRAS—lung cancer	2.92e-05	0.000442	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—RAF1—lung cancer	2.85e-05	0.000431	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—STK11—lung cancer	2.7e-05	0.000408	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—GSTP1—lung cancer	2.5e-05	0.000377	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CAT—lung cancer	2.43e-05	0.000367	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—ABCB1—lung cancer	2.36e-05	0.000357	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—TYMS—lung cancer	2.32e-05	0.000351	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—GSTM1—lung cancer	2.29e-05	0.000347	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CYP1A1—lung cancer	2.17e-05	0.000329	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—ERCC2—lung cancer	2.16e-05	0.000326	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—APOA1—lung cancer	1.87e-05	0.000282	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—PIK3CG—lung cancer	1.7e-05	0.000257	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—POMC—lung cancer	1.62e-05	0.000245	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CREBBP—lung cancer	1.58e-05	0.000239	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—PIK3CD—lung cancer	1.5e-05	0.000226	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—ALB—lung cancer	1.48e-05	0.000223	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—PIK3CB—lung cancer	1.31e-05	0.000197	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—PTGS2—lung cancer	1.29e-05	0.000195	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—PTEN—lung cancer	1.13e-05	0.00017	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—EP300—lung cancer	1.08e-05	0.000163	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—PIK3CA—lung cancer	7.96e-06	0.00012	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—AKT1—lung cancer	6.5e-06	9.83e-05	CbGpPWpGaD
